The sentence is in. Despite pleas for sentencing mercy, “Pharma Bro” Martin Shkreli will spend up to seven years in prison on federal securities fraud charges. More: No leniency for Shkreli: Bad-boy pharma executive gets 7 years in prison for
read moreAs the American College of Cardiology’s annual meeting kicked off in Orlando Saturday, all eyes turned to Sanofi and Regeneron, who reported that their PCSK9 med Praluent reduced the risk of cardiovascular events by 15%—as well as all-cause mortality by
read moreA pay-for-delay case against GlaxoSmithKline and its one-time top seller Paxil that has been kicking around for years has finally been decided, and GSK lost. More: GSK appeal of pay-for-delay fine falls short, drugmaker told to pay M Source: fierce
read moreA judge has ordered 1,200 Xarelto liability cases against Johnson & Johnson and Bayer to be prepared for trial in courts around the country. More: Judge orders 1,200 Xarelto liability cases to be prepped for trials Source: fierce
read morePfizer just got some backup on its quest to snag a nod for ulcerative colitis med Xeljanz. On Thursday, the FDA’s GI drugs advisory committee voted unanimously to approve the drug, even recommending a green light for a higher 10-mg
read moreSanofi is off the hook with the U.S. Justice Department in a foreign bribery investigation that has been going on for some years, but the company still isn’t entirely in the clear with other U.S. regulators. More: Sanofi says DOJ foreign
read more© 1994 - 2026 B.M. Pharmaceuticals